Figure 2From: Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study Change in vitreous haze at months 3 and 6 in patients with active uveitis at baseline. Back to article page